Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Vagus Nerve Stimulation for Treatment of Partial Seizures: 2. Safety, Side Effects, and Tolerability

Ramsay, R. E., Uthman, B. M., Augustinsson, L. E., Upton, A. R. M., Naritoku, D., Willis, J., Treig, T., Barolat, G., Wernicke, J. F., First International Vagus Nerve Stimulation Study Group·1994·Epilepsia

Abstract

Summary: Vagus nerve stimulation (VNS) significantly reduces the frequency of partial seizures in refractory epilepsy patients. We examined the serious adverse events, side effects, and tolerability as they relate to the surgical implant procedure and the stimulating device.We also reviewed potential drug interactions, device out‐put complications, and impact of the therapy on overallhealth status. We analyzed the first 67 patients to exit theacute phase of the EO3 VNS trial comparing high (therapeutic) VNS to low (less or noneffective) VNS. Datawere collected from case report forms used at each of thefour visits during the 12‐week baseline and at each of thefour visits during the 14‐week randomized phase of the trial. No significant complications were reported as a re‐sult of the implant procedure. Serious adverse events in‐cluded 1 patient who experienced direct current to thevagus nerve owing to generator malfunction resulting inleft vocal cord paralysis and withdrawal of the patientfrom the study. No clinically significant effects on vitalsigns, cardiac function, or gastric function were detected. Side effects associated with VNS in the high group werehoarseness (35.5%), coughing (13.9%), and throat pain(12.9%). In the low group, only hoarseness (13.9%) andthroat pain (13.9%) were associated with VNS. Theseeffects generally were not considered clinically significantand occurred primarily during the stimulation pulses. Nopatients discontinued VNS therapy during the acutephase because of side effects associated with normal stimulation. Except for the one instance of a short circuitin the system resulting in a direct current, stimulatingsystem complications were minor, limited to programming, unscheduled stimulation, and high lead impedance.Patients, investigators, and patient companions rated patients receiving high stimulation as more “improved” than those receiving low stimulation in regards to overallhealth status. Antiepileptic drug (AED) plasma concentrations were not affected by VNS. The implant procedure, stimulating system, and therapy proved safe andtolerable during the study. The high percentage (67 of 68)of patients completing the study reflects patient acceptance and tolerability of this mode of therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1528-1157.1994.tb02483.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 260

Metadata

Authors
Ramsay, R. E., Uthman, B. M., Augustinsson, L. E., Upton, A. R. M., Naritoku, D., Willis, J., Treig, T., Barolat, G., Wernicke, J. F., & First International Vagus Nerve Stimulation Study Group
Venue
Epilepsia
Publisher
Wiley
Published
1994-05
Volume
35
Issue
3
Pages
627-636
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2068060099
Cited by
260
References
8
FWCI
2.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vagus Nerve Stimulation for Treatment of Partial Seizures: 2. Safety, Side Effects, and Tolerability. https://app.cochat.ai/papers/10.1111/j.1528-1157.1994.tb02483.x
The paper
Ramsay, R. E., Uthman, B. M., Augustinsson, L. E., Upton, A. R. M., Naritoku, D., Willis, J., Treig, T., Barolat, G., Wernicke, J. F., & First International Vagus Nerve Stimulation Study Group. (1994). Vagus Nerve Stimulation for Treatment of Partial Seizures: 2. Safety, Side Effects, and Tolerability. Epilepsia. https://doi.org/10.1111/j.1528-1157.1994.tb02483.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.